Preservative effect of aprotinin on canine plasma immunoreactive adrenocorticotropin concentrations.
The susceptibility of adrenocorticotropin (ACTH) in canine blood and plasma to enzymatic degradation has limited the availability of endogenous ACTH assay for veterinary use. This study examined if a proteinase (enzyme) inhibitor, aprotinin, mixed with blood at the time of collection, would limit the loss of immunoreactive (IR) ACTH from canine plasma stored at various temperatures. Blood was collected from laboratory-maintained dogs or dogs with hyperadrenocorticism and placed into EDTA-containing tubes in the presence or absence of aprotinin. Plasma obtained was stored for 4 d at temperatures ranging from -86 degrees C to room temperature (22 degrees C). Results showed that addition of aprotinin preserved IR-ACTH concentrations in plasma stored for 4 d at temperatures < or = 4 degrees C, or in unfrozen plasma stored inside insulated shipping containers containing frozen refrigerant packs. Plasma collected with aprotinin and stored at 22 degrees C showed a slight (17-23%) but significant (P < 0.05) decline in IR-ACTH. Unfrozen plasma collected without aprotinin showed significant (P < 0.05) loss of IR-ACTH during storage under identical conditions. These data indicate that aprotinin has a profound preservative effect upon canine plasma IR-ACTH and that it may be possible to submit unfrozen samples collected with this inhibitor to appropriate reference laboratories for analysis of IR-ACTH.
Kemppainen
R J
RJ
Department of Physiology and Pharmacology, Auburn University College of Veterinary Medicine, AL 36849.
Clark
T P
TP
Peterson
M E
ME
D000324:Adrenocorticotropic Hormone / Q000097:blood* / Q000187:drug effects*; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology*; D001793:Blood Preservation / Q000379:methods / Q000662:veterinary*; D004285:Dogs / Q000097:blood*; D005260:Female; D008297:Male; D011863:Radioimmunoassay / Q000662:veterinary
D000324:Adrenocorticotropic Hormone; D007611:Aprotinin